Vascular robotics is growing fast and Corindus is the leader here, but Healthineers will need an aggressive sales plan.
The deal is 2019’s second-biggest medtech flotation, and the fourth-biggest ever.
Exact Sciences finds that where there’s muck there’s brass, but specialisation does not work as well for Abiomed.
The value of listings hit a new quarterly high courtesy of Guardant and Axonics.
Big medtech is keeping its purse-strings closed – but private equity sees value in subsidiaries.
Since becoming a pure-play health tech group Philips has been buying like crazy. Might Siemens Healthineers and GE Healthcare join in?
Big cap medtech is hiring, largely thanks to organic growth.
Nine IPOs have got away so far this year, and one of them is very big indeed.
GE arrives to the spin-out party fashionably late.